OpenLobby.EU
Explore

European Biosolutions Coalition

EBC

The purpose of the Coalition is to promote biosolutions, biotechnology and biomanufacturing on a European as well as national level.

Lobbying Activity

Meeting with Anna Nykiel-mateo (Cabinet of Executive Vice-President Stéphane Séjourné)

16 Jan 2026 · European Biosolutions Coalition requested the meeting to introduce their work and discuss the Biotech Acts I and II.

Meeting with Vilija Sysaite (Cabinet of Executive Vice-President Stéphane Séjourné)

12 Nov 2025 · Biotech

Meeting with Ekaterina Zaharieva (Commissioner) and

11 Nov 2025 · Bioeconomy

Meeting with Stine Bosse (Member of the European Parliament) and Novonesis A/S

23 Oct 2025 · Event planning: value of biosolutions report launch

Meeting with Vilija Sysaite (Cabinet of Executive Vice-President Stéphane Séjourné)

20 Aug 2025 · Bioeconomy strategy and Biotech Act

Meeting with Vilija Sysaite (Cabinet of Executive Vice-President Stéphane Séjourné)

3 Jul 2025 · Biotech

Response to Towards a Circular, Regenerative and Competitive Bioeconomy

23 Jun 2025

Bioeconomy is key to addressing many of the challenges faced by the EU and the world today. Europe leads the world in research, technology, and availability of bioresources, with significant potential for growth, particularly in rural areas. Therefore, the European Biosolutions Coalition welcomes the European Commission's ambition to build a circular, regenerative, and competitive bioeconomy. However, the coalition emphasizes the importance of setting out long-term directions for related initiatives and legislations, such as the Biotech Act and measures for simplification within the bioeconomy. To ensure success, the European Biosolutions Coalition underscores that the Biotech Act should be ambitious and broad, encompassing all relevant sectors, including healthcare, food and feed, agriculture, materials (including construction materials), industrial and environmental biotechnology, and marine biotechnology. Furthermore, as part of the Biotech Act and Bioeconomy Strategy, the coalition believes it is essential to ensure the alignment of definitions across relevant legislation, such as product legislation allowing for faster approval processes of compounds (for instance in pesticide legislation), quicker approval of production facilities (Net Zero Industry Act), and measurement of economic activity (NACE codes). Bioeconomy can drive economic growth and competitiveness while significantly contributing to our climate and environmental ambitions. Resource efficiency is beneficial for both business and environmental policy, from reducing food waste throughout the value chain to the use of wood. When bioresources are fully utilized, less land is needed to feed the global population, leaving more space for nature and biodiversity, while companies earn more per unit of raw material. Therefore, resource efficiency is critical to Europe's competitiveness, reduced climate impact, decreased dependency on fossil resources, and improved conditions for biodiversity. The European Biosolutions Coalition supports the cascade principle and recommends that the EU Bioeconomy Strategy prioritize according to the bioeconomic value pyramid, as described by L. Lange. See attached file for further input.
Read full response

Response to Biotech Act

11 Jun 2025

EBC appreciate the opportunity to comment on the Call for Evidence for a future Biotech Act. We strongly support the development of a Biotech Act, the description of the rationale behind and the positive impact it will have for the sector and European competitiveness as described in the Call for Evidence. To ensure its success EBC agrees the Biotech Act should be bold and broad and include all relevant sectors i.e. both healthcare as well as food and feed, agriculture, materials (incl. materials for construction), industrial and environmental, and marine biotechnology. EBC supports the focus on exploring the five areas i.e. 1) Speed and streamlining, 2) Financing, 3) Scale, 4) Skills and 5) Use of data and AI in the biotech and biomanufacturing sector. See below for more specific comments. As part of the Biotech Act and the bioeconomy strategy EBC believes it is important also to ensure alignment of definitions across relevant legislation i.e. for relevant product legislation allowing for faster approval processes of compounds (for instance in the pesticides legislation), faster approval of production facilities (Net Zero Industry Act) and measurement of economic activity (NACE codes). That could be included in the Call for Evidence. For more details please see attached file with feedback:
Read full response

Meeting with Morten Løkkegaard (Member of the European Parliament, Shadow rapporteur) and Confederation of Danish Industry

13 May 2025 · Biotechnology & Biosolutions

Meeting with Ilaria Flores Martin (Cabinet of Commissioner Jessika Roswall)

24 Mar 2025 · Logistical preparation for the Conference and brief discussion on the Commission’s upcoming Bio-economy Strategy

Meeting with Vesa Terävä (Head of Unit Secretariat-General)

19 Mar 2025 · Information on the work of the Coalition and discussion about future Commission proposals like the Biotech Act.

Meeting with Pernille Weiss-Ehler (Cabinet of Commissioner Jessika Roswall)

18 Mar 2025 · The upcoming EU Bioeconomy Act

Meeting with Klaus Berend (Director Health and Food Safety) and

11 Feb 2025 · Exchange on the Commission biotech initiatives.

Meeting with Andreea Ticheru (Cabinet of Executive Vice-President Margrethe Vestager)

8 Mar 2024 · EU Biotech and Biomanufacturing Initiative